市場調查報告書

全球神經調節市場調查與預測

Global Neuromodulation Market Research and Forecast, 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 825135
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球神經調節市場調查與預測 Global Neuromodulation Market Research and Forecast, 2019-2025
出版日期: 2019年03月28日內容資訊: 英文
簡介

本報告提供全球神經調節市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介等相關資訊。

第1章 報告的摘要

第2章 市場概要與趨勢

第3章 競爭環境

  • 競爭儀表板
  • 主要策略分析
  • 主要企業分析

第4章 市場決策因素

  • 促進要素
  • 阻礙要素
  • 機會

第5章 市場區隔

  • 各技術市場
    • 體內神經調節
    • 體外神經調節
  • 各用途
    • 慢性疼痛
    • 帕金森氏症
    • 強迫性精神官能症
    • 治療抗性憂鬱症
    • 尿·便疾病
    • 其他

第6章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第7章 企業簡介

  • Abbott Laboratories Inc.
  • Aleva Neurotherapeutics SA
  • Axonics Modulation Technologies, Inc.
  • Bioness Inc.
  • Boston Scientific Corp.
  • Cogentix Medical, Inc.
  • Cyberonics Inc.
  • Integer Holdings Corp.
  • LABORIE Medical Technologies Inc.
  • LivaNova, PLC
  • Medtronic PLC
  • Neuronetics Inc.
  • NeuroPace Inc.
  • NeuroRecovery Technologies Inc.
  • Neurosigma Inc.
  • Neuspera Medical Inc.
  • Nevro Corp.
  • PathMaker Neurosystems Inc.
  • Soterix Medical Inc.
  • Synapse Biomedical Inc.
  • Tivic Health Systems Inc.
  • Xavant Technology
目錄
Product Code: OMR2019610

Global Neuromodulation Market Size, Share & Trends Analysis Report by Technology (Internal Neuromodulation, External Neuromodulation), by Application (Chronic Pain, Parkinson's Disease, Obsessive Compulsive Disorder (OCD), Treatment-Resistant Depression (TRD), Urinary and Fecal Disorders, and Others) and Forecasts, 2019 - 2025.

Neurological disorders such as Alzheimer disease, cerebrovascular disease, and Parkinson's disease, affect the central and peripheral nervous system. Neuromodulation is a technique that is used for managing and treating such disorders. The proven efficacy and improving acceptance of neuromodulation technology are the factors that are expected to contribute to the growth of the global neuromodulation market during the forecast period.

The major factors contributing to the growth of the global neuromodulations market include the rising prevalence of neurological disorders such as cerebrovascular diseases and Parkinson's disease. Further, the geriatric population base is at high risk of developing such disorders, thereby increasing population pool with the aged people further gives a boost to the growth of the market. In addition, a robust product pipeline along with the presence of a large number of market players further augments the growth of the global neuromodulation market. However, there are certain factors such as lack of skilled professionals and strict regulatory framework, that may hamper the growth of the market.

The global neuromodulation market is segmented on the basis of technology, application, as well as regional outlook. On the basis of technology, the market is further diversified into internal neuromodulation and external modulation. Based on the application, the market is further sub-segmented into chronic pain, Parkinson disease, OCD, TRD, urinary and fecal disorders, and others. The market is geographically analyzed into North America, Europe, Asia-Pacific, and rest of the World. North America is estimated to have a significant share, while Asia-Pacific is estimated to exhibit a considerable growth rate in the global neuromodulation market.

The major players operating in the market include Medtronic PLC, Boston Scientific Corp., Abbott Laboratories Inc., Synapse Biomedical Inc., and Nevro Corp., among others. The increasing efforts by the players in making innovation and rise in investment for various public and private organizations are expected to strengthen the industry competition across the globe.

Research Methodology

The market study of the global neuromodulation market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Authentic Public Databases such as the National Institute of Health and International Neuromodulation Society.
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog

The report is intended for neurostimulator devices manufacturers, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  • 1. Global Neuromodulation Market Research and Analysis by Technology
  • 2. Global Neuromodulation Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global neuromodulation market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global neuromodulation market.
  • Insights about market determinants which are stimulating the global neuromodulation market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules &Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Medtronic PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Boston Scientific Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Abbott Laboratories Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. LivaNova PLC
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Nevro Corp.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Neuromodulation Market by Technology
    • 5.1.1. Internal Neuromodulation
      • 5.1.1.1. Spinal Cord Stimulation (SCS)
      • 5.1.1.2. Deep Brain Stimulation (DBS)
      • 5.1.1.3. Sacral Nerve Stimulation (SNS)
      • 5.1.1.4. Vagus Nerve Stimulation (VNS)
      • 5.1.1.5. Gastric Electrical Stimulation (GES)
    • 5.1.2. External Neuromodulation
      • 5.1.2.1. Transcutaneous Electrical Nerve Stimulation (TENS)
      • 5.1.2.2. Transcranial Magnetic Stimulation (TMS)
      • 5.1.2.3. Respiratory Electrical Stimulation (RES)
  • 5.2. Global Neuromodulation Market by Application
    • 5.2.1. Chronic Pain
    • 5.2.2. Parkinson's Disease
    • 5.2.3. Obsessive Compulsive Disorder (OCD)
    • 5.2.4. Treatment-Resistant Depression (TRD)
    • 5.2.5. Urinary and Fecal Disorders
    • 5.2.6. Others (Ischemia, Epilepsy)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Aleva Neurotherapeutics SA
  • 7.3. Axonics Modulation Technologies, Inc.
  • 7.4. Bioness Inc.
  • 7.5. Boston Scientific Corp.
  • 7.6. Cogentix Medical, Inc.
  • 7.7. Cyberonics Inc.
  • 7.8. Integer Holdings Corp.
  • 7.9. LABORIE Medical Technologies Inc.
  • 7.10. LivaNova, PLC
  • 7.11. Medtronic PLC
  • 7.12. Neuronetics Inc.
  • 7.13. NeuroPace Inc.
  • 7.14. NeuroRecovery Technologies Inc.
  • 7.15. Neurosigma Inc.
  • 7.16. Neuspera Medical Inc.
  • 7.17. Nevro Corp.
  • 7.18. PathMaker Neurosystems Inc.
  • 7.19. Soterix Medical Inc.
  • 7.20. Synapse Biomedical Inc.
  • 7.21. Tivic Health Systems Inc.
  • 7.22. Xavant Technology

List of Tables

  • 1. GLOBAL NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 2. GLOBAL INTERNAL NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL EXTERNAL NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 5. GLOBAL CHRONIC PAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL PARKINSON'S DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL OBSESSIVE COMPULSIVE DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL TREATMENT-RESISTANT DEPRESSION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025
  • 9. GLOBAL URINARY AND FECAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICAN NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 15. EUROPEAN NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. EUROPEAN NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 17. EUROPEAN NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 21. REST OF THE WORLD NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 22. REST OF THE WORLD NEUROMODULATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL NEUROMODULATION MARKET SHARE BY TECHNOLOGY, 2018 VS 2025(%)
  • 2. GLOBAL NEUROMODULATION MARKET SHARE BY APPLICATION, 2018 VS 2025(%)
  • 3. GLOBAL NEUROMODULATION MARKET SHARE BY GEOGRAPHY, 2018 VS 2025(%)
  • 4. US NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 5. CANADA NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 6. UK NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 7. FRANCE NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 8. GERMANY NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 9. SPAIN NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 10. ITALY NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 11. REST OF EUROPE NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 12. INDIA NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 13. CHINA NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 14. JAPAN NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 15. REST OF ASIA-PACIFIC NEUROMODULATION MARKET SIZE, 2018-2025($ MILLION)
  • 16. REST OF THE WORLD TRANSFORMER MONITORING SYSTEM MARKET SIZE, 2018-2025($ MILLION)